We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Ingevity
NGVT
$2.55B
| $9.58M | 0.01% |
219,146
-147,825
| -40% | -$7.14M |
|
|
ESPR
727
DELISTED
Esperion Therapeutics
ESPR
| $9.55M | 0.01% |
4,303,596
+2,087,635
| +94% | +$4.91M |
|
728
LXP Industrial Trust
LXP
$3.53B
| $9.55M | 0.01% |
209,449
+108,009
| +106% | +$4.73M |
|
729
G-III Apparel Group
GIII
$1.47B
| $9.53M | 0.01% |
351,918
+206,993
| +143% | +$5.8M |
|
|
PARA
730
DELISTED
Paramount Global Class B
PARA
| $9.52M | 0.01% |
915,785
-8,124,661
| -90% | -$95.2M |
|
731
Banco Macro
BMA
$5.7B
| $9.49M | 0.01% |
165,558
+69,494
| +72% | +$3.98M |
|
732
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $9.47M | 0.01% |
207,800
+206,000
| +11,444% | +$9.59M |
|
733
Deere & Co
DE
$170B
| $9.45M | 0.01% |
25,289
-64,013
| -72% | -$25M |
|
734
Rush Street Interactive
RSI
$3.24B
| $9.42M | 0.01% |
981,822
+637,883
| +185% | +$5.11M |
|
735
Cimpress
CMPR
$2.37B
| $9.4M | 0.01% |
107,350
+93,033
| +650% | +$8.11M |
|
736
Genpact
G
$5.3B
| $9.35M | 0.01% |
290,379
+283,082
| +3,879% | +$9.13M |
|
737
NextEra Energy
NEE
$187B
| $9.34M | 0.01% |
131,866
+122,691
| +1,337% | +$8.71M |
|
738
Oscar Health
OSCR
$8.5B
| $9.33M | 0.01% |
+589,702
| New | +$10.8M |
|
739
HCI Group
HCI
$2.28B
| $9.33M | 0.01% |
101,188
-3,777
| -4% | -$394K |
|
740
Suzano
SUZ
$10.2B
| $9.31M | 0.01% |
+906,496
| New | +$9.53M |
|
741
Waters Corp
WAT
$36.8B
| $9.3M | 0.01% |
+32,039
| New | +$10.2M |
|
|
MRO
742
DELISTED
Marathon Oil Corporation
MRO
| $9.29M | 0.01% |
324,022
+215,644
| +199% | +$5.98M |
|
743
Hubbell
HUBB
$25.7B
| $9.29M | 0.01% |
+25,414
| New | +$9.97M |
|
|
JKS
744
JinkoSolar
JKS
$775M
| $9.28M | 0.01% |
447,709
+148,268
| +50% | +$3.65M |
|
745
Citigroup
C
$222B
| $9.24M | 0.01% |
145,659
+144,959
| +20,708% | +$8.94M |
|
746
CNA Financial
CNA
$14.5B
| $9.24M | 0.01% |
200,495
-46,687
| -19% | -$2.07M |
|
747
Harmony Biosciences
HRMY
$2.04B
| $9.22M | 0.01% |
305,612
+181,092
| +145% | +$5.45M |
|
748
Noble Corp
NE
$6.9B
| $9.21M | 0.01% |
206,184
+33,996
| +20% | +$1.57M |
|
749
WEC Energy
WEC
$37.7B
| $9.17M | 0.01% |
116,908
-12,357
| -10% | -$1M |
|
750
Oaktree Specialty Lending
OCSL
$1.03B
| $9.15M | 0.01% |
486,495
-79,009
| -14% | -$1.53M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.